In the realm of pancreatic branch-duct intraductal papillary mucinous neoplasms (bd-IPMNs), spotting malignancy is tricky. However, researchers delving into 58 cases discovered a game-changer. The standardized uptake value (SUV) from FDG-PET/CT, specifically the tumor-to-blood pool ratio (TBR), emerged as a potent indicator of malignancy. Correlating significantly with histopathology, TBR proved independently significant in scenarios defining […]
Author: STITCHES Newsletter
Preventing Obstruction: Identifying Risk Criteria for Colon Cancer Patients Undergoing Neoadjuvant Chemotherapy
In the FOxTROT trial, analyzing high-risk colon cancer patients undergoing neoadjuvant chemotherapy (NAC), researchers identified pre-treatment risk criteria to stratify obstruction risk. Among 699 patients, 4.3% developed obstruction. Two independent criteria, obstructing disease on endoscopy or inability to pass through the tumor, and stricturing disease on radiology or endoscopy, were associated with higher risk. This […]
Enhancing Training for Surgical Oncology Excellence
Complex General Surgical Oncology (CGSO) fellowship graduates, while generally feeling prepared for practice, expressed concerns about research and specific clinical areas like thoracic, hyperthermic intraperitoneal chemotherapy (HIPEC), and hepato-pancreato-biliary surgery. The study reveals potential gaps between trainee expectations and surgical oncology practice realities, suggesting opportunities to refine the training model. Improvements, such as increased autonomy, […]
Navigating Neoadjuvant Uncertainty: Ampullary and Duodenal Adenocarcinoma Management
The study delves into the uncertain territory of neoadjuvant therapy (NAT) for ampullary (AA) and duodenal adenocarcinoma (DA). Analyzing 15 retrospective studies, no clear survival differences were found between NAT and upfront surgery. While some studies hinted at benefits like increased pathologic response, overall evidence supporting NAT for AA and DA is weak. The research […]
Social Vulnerability Delays Treatment: Impact on Primary Hyperparathyroidism Evaluation
In a Massachusetts study on primary hyperparathyroidism, researchers found that patients in socially vulnerable groups faced delays in surgeon evaluation, contributing to heightened risks of long-term complications. Among 1,082 patients, those in the highest vulnerability quartile had a 33% lower surgeon evaluation rate and were seen 67 days later than those in the lowest quartile. […]
Remote Ischemic Preconditioning Falls Short in Liver Protection Post-Hepatectomy
In a randomized trial involving 102 patients with chronic liver disease undergoing hepatectomy, remote ischemic preconditioning’s anticipated liver-protective benefits were not realized. Despite inducing preconditioning through upper extremity cycles of ischemia and reperfusion, the study showed no significant reduction in postoperative transaminase levels. The results suggest limited efficacy in mitigating ischemia-reperfusion injury, challenging the application […]
Prophylactic Mesh Fails to Halt Long-Term Parastomal Hernias
In a comprehensive review of eight randomized trials with 537 patients, the long-term efficacy of prophylactic mesh during end colostomy creation was debunked. Contrary to prior expectations, the incidence of parastomal hernia showed no significant reduction, challenging the strategy’s effectiveness. Both parastomal hernia repair rates and mortality remained comparable between mesh and non-mesh groups, with […]
Shrinking Tumors, Elevating Hope: FOLFIRINOX Impact on Pancreatic Cancer Resectability and Survival
In pancreatic cancer patients receiving FOLFIRINOX, tumor size reduction significantly increased resectability and pathologic response. Normalization of carbohydrate antigen 19-9 levels predicted resectability, lower recurrence risk, and improved survival. Postoperative antigen 19-9 rise, following prior normalization after neoadjuvant therapy, signaled heightened recurrence risk and poorer survival. Tailoring treatment response assessments can guide personalized strategies for […]
Sarcopenia Signals Poor Outcomes in Recurrent Hepatocellular Carcinoma
Patients with early-stage recurrent hepatocellular carcinoma and sarcopenia face significantly lower overall and recurrence-free survival rates, regardless of treatment type. Sarcopenia emerges as an independent prognostic factor, suggesting a crucial role in long-term outcomes. Notably, impaired host immunity, evidenced by low levels of tumor-infiltrating lymphocytes, may contribute to the unfavorable prognosis. This study underscores the […]
Optimizing Laparoscopic Pancreaticoduodenectomy: ‘1+2’ Stitch Shows Superiority in Pancreaticojejunostomy
In a game-changing move, researchers explored the “1+2” technique for pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy. Among 184 cases, this approach exhibited success in all 95 “1+2” cases, showcasing advantages over the traditional method. The new technique boasted shorter operation and pancreaticojejunostomy times, reduced complications, lower infection rates, and briefer hospital stays. Results suggest that this innovative […]